Group 1 - The core viewpoint of the article emphasizes the importance of timely and relevant research reports in identifying investment opportunities, particularly in emerging fields like brain-computer interfaces [1] - Neuralink, led by Elon Musk, is set to begin large-scale production of brain-computer interface devices in 2026, marking a significant milestone in the integration of life sciences and information technology [1] - The brain-computer interface sector is experiencing rapid technological advancements and policy support, with expectations for commercialization to expand into AI applications and robotics by 2026 [1] Group 2 - The article highlights five key focus areas for investment as the humanoid robot sector approaches critical production milestones, with supply chains becoming more consolidated [2] - The AI wave is driving significant increases in storage prices, with DRAM prices soaring by 171.8%, while domestic wafer manufacturers are accelerating "domestic substitution" in response to tightening overseas restrictions [2] - New policies in Guangdong are encouraging insurance capital to enter the market, providing a dual boost to insurance stocks through asset and liability management [2] - A major state-owned enterprise has invested 1 billion in Thunderbird Innovation, signaling an imminent explosion in the AI glasses sector [2]

智通财经APP讯，三博脑科(301293.SZ)公告称，公司股票于2026年1月5日、1月6日，连续2个交易日内 日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动的情形。公司是以神经专科为特色的医疗 服务集团，下属院区主要为患者提供以高精尖神经外科为主的综合医疗服务。公司目前不涉及脑机接口 产品的研发、生产及销售，神经调控技术带来的收入占公司营业收入比重很小，对公司业绩基本没有影 响。 ...

三博脑科股票交易异常波动公告，公司是以神经专科为特色的医疗服务集团，下属院区主要为患者提供 以高精尖神经外科为主的综合医疗服务。公司目前不涉及脑机接口产品的研发、生产及销售，神经调控 技术带来的收入占公司营业收入比重很小，对公司业绩基本没有影响，敬请注意投资风险。 ...

南财智讯1月6日电，三博脑科公告，公司股票于2026年1月5日、1月6日连续2个交易日内日收盘价格涨 幅偏离值累计超过30%，根据深圳证券交易所交易规则，属于股票交易异常波动的情形。针对上述情 况，公司通过函询及通讯方式向控股股东、实际控制人进行了核实，确认前期披露的信息不存在需要更 正或补充之处；近期公共传媒未报道与公司相关且市场关注度较高的信息；公司经营情况及内外部经营 环境未发生重大变化；公司、控股股东和实际控制人不存在应披露而未披露的重大事项，也未在筹划相 关重大事项；股票异常波动期间，控股股东及实际控制人未买卖公司股票。公司董事会确认，目前没有 任何应予以披露而未披露的事项，亦未获悉可能对公司股票交易价格产生较大影响的信息。公司同时提 示，目前正在进行2025年年度财务核算，若触及业绩预告披露标准将按规定及时披露；公司不涉及脑机 接口产品的研发、生产及销售，神经调控技术相关收入占比较小，对公司业绩基本无影响，请投资者注 意投资风险。 ...

证券代码：301293 证券简称：三博脑科 公告编号：2026-001 三博脑科医院管理集团股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 三博脑科医院管理集团股份有限公司（以下简称"公司"）股票于 2026 年 1 月 5 日、1 月 6 日，连续 2 个交易日内日收盘价格涨幅偏离值累计超过 30%，根 据《深圳证券交易所交易规则》的规定，属于股票交易异常波动的情形。 5、股票异常波动期间控股股东、实际控制人未买卖公司股票。 二、公司关注、核实情况的说明 针对公司股票异常波动情况，公司通过函询及通讯方式，向公司控股股东、 实际控制人就相关问题进行了核实，现就相关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、近期公共传媒未报道与公司相关且市场关注度较高的信息； 3、近期公司经营情况及内外部经营环境未发生重大变化； 4、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项，或处于筹划阶段的重大事项； 三、是否存在应披露而未披露信息的说明 公司董事会确认，公 ...

1月6日，三大指数集体收涨，沪指高开高走，再创十年新高。截至收盘，沪指涨1.5%，报4083.67点，创10年新高；深证成指涨1.4%，报14022.55点；创业 板指涨0.75%，报3319.29点。量能持续放大，沪深两市成交额2.81万亿，较上一个交易日放量2602亿。盘面上，市场热点轮番活跃，全市场超4100只个股上 涨，多达143只个股涨停，连续两日超百股涨停。 从板块来看，商业航天概念持续爆发，十余只成分股涨停，鲁信创投8天6板，北斗星通、中国卫通6天4板。脑机接口概念延续强势，三博脑科、美好医疗、 创新医疗2连板。大金融板块集体拉升，华林证券、大智慧涨停。智能驾驶概念走强，万集科技、路畅科技等多股涨停。化工板块走高，中泰化学、潞化科 技、氯碱化工涨停。有色金属板块表现活跃，洛阳钼业、紫金矿业等多股创历史新高。 今日市场（不含ST股、退市股）共120股涨停，连板股总数43只，25股封板未遂，封板率为83%。焦点股方面，胜通能源13连板、嘉美包装16天12板、锋龙 股份8连板、鲁信创投8天6板、雷科防务5连板、浙江世宝14天7板、三博脑科2天2板。 一、板块异动 二、涨跌停温度 三、涨跌家数 四、涨停 ...

1月6日，三大指数集体收涨，两市成交额高达2.81万亿。其中，上证指数高开高走，收涨1.50%，报 4083.67点，刷新2015年7月底以来新高。并实现日线13连阳，创史上最长连阳记录。 回顾A股历史，上证指数10连阳以上的行情十分罕见。仅在1992年2月25日至3月11日实现12连阳，以及 分别在1992年5月、2006年6月、2017年12月至2018年1月录得三次11连阳。 梳理发现，指数连阳行情往往伴随后续趋势性上涨。上证指数曾在2006年6月实现11连阳后，便开始持 续攀升，最终在2007年10月突破6000点大关，期间累计涨幅超260%。 从板块表现来看，6日市场热点板块全面开花。脑机接口概念涨幅居前，三博脑科、美好医疗、创新医 疗2连板；商业航天概念持续爆发，十余只成分股涨停，鲁信创投8天6板，北斗星通、中国卫通6天4 板。分析指出，科技牛是2025年贯穿全年的一个重要特征，2026年科技牛行情有望继续延续。 而本轮上证指数的强势表现早有端倪。2025年全年，上证指数累计上涨18.41%，深证成指上涨 29.87%，创业板指更是大涨近50%。 2026年第一个交易日，上证指数延续涨势收涨1.3 ...

Market Performance - The A-share market opened the year with a strong performance, with the Shanghai Composite Index achieving a rare 13 consecutive days of gains, closing at a ten-year high of 4083.67 points, up 1.5% [2] - The Shenzhen Component Index and the ChiNext Index also saw increases of 1.4% and 0.75% respectively, indicating a broad market rally [2] - Over 140 stocks hit the daily limit up, and the total trading volume exceeded 2.8 trillion yuan [1][2] Sector Performance - The commercial aerospace sector showed significant strength, with multiple stocks hitting the daily limit up, including Luxin Venture Capital and Beidou Star Communication [2] - The brain-computer interface concept also saw a surge, with stocks like Sanbo Brain Science and Meihao Medical achieving consecutive gains [2] - The financial sector collectively rose, with companies like Hualin Securities and Dazhihui hitting the daily limit up [2] - The non-ferrous metals sector was active, with companies like Luoyang Molybdenum and Zijin Mining reaching historical highs [2] Economic Factors - Analysts attribute the strong performance of the A-share market to multiple positive factors, including improved market sentiment post-New Year and expectations of long-term capital inflows from insurance funds [3] - The macroeconomic growth policies and anticipated industry policy details related to new productivity have also contributed to the rising index [3] Company Highlights - Zijin Mining's stock rose over 6%, closing with a gain of 6.21%, leading to a market capitalization exceeding 1 trillion yuan, making it the first mining company in A-shares to reach this milestone [4] - Zijin Mining expects a net profit of approximately 51-52 billion yuan for 2025, a year-on-year increase of about 59%-62%, driven by increased production of key minerals [4] - The rise in international gold prices, influenced by geopolitical tensions, has also positively impacted Zijin Mining's performance [5] Consumer Market Impact - The increase in international gold prices has led to domestic jewelry brands like Chow Sang Sang raising their gold jewelry prices by 200 to 1500 yuan [6][8] - The price of gold jewelry is expected to continue rising, reflecting a structural change in consumer preferences towards smaller, high-design products and investment gold products [8] Market Outlook - Goldman Sachs has maintained an "overweight" rating on the A-share market, projecting a target increase of 15%-20% for the Shanghai Composite Index in 2026 [9] - Other institutions also express optimism for the A-share market, predicting a transition from valuation recovery in 2025 to profit-driven growth in 2026 [9]

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing a surge in interest and investment following Elon Musk's announcement of mass production plans for BCI devices by Neuralink in 2026, leading to significant stock price increases in related companies [1][2][3] Market Reaction - On January 5, the A-share BCI sector index rose by 13.7% to 1861.12 points, and on January 6, it opened at 1956.76 points, peaking at 1973.98 points, closing at 1967.92 points, resulting in a cumulative increase of 20.22% over two trading days [1][2] - 19 concept stocks experienced consecutive trading halts, with notable gains such as Beiyikang, which saw a cumulative increase of 69.95%, reaching 58.44 yuan per share [2] Industry Growth Potential - The global BCI market is projected to reach approximately $2.6 billion in 2024, with China's market expected to be around 3.2 billion yuan; by 2034, the global market is anticipated to grow to about $12.4 billion [3] - The BCI industry is expected to see an annual growth rate of around 20% in China from 2024 to 2028, significantly outpacing traditional manufacturing sectors [3] Policy and Technological Support - The Chinese government has set clear development goals for the BCI industry through policies issued by multiple departments, aiming to promote innovation and application across various sectors beyond medical rehabilitation [4][5] - The introduction of separate billing for BCI projects by the National Healthcare Security Administration addresses key payment issues, facilitating industry development [4] Competitive Landscape - China is positioned in the leading tier of global BCI research, with over 800 core enterprises in the BCI industry chain, primarily located in the U.S. and China [5] - The market is seeing a mix of invasive and non-invasive technologies, with successful clinical trials for invasive BCIs marking significant progress in the field [5] Investment Trends - Investment enthusiasm in the BCI sector is rising, with 14 financing events in the first half of 2025, totaling over 800 million yuan, and BCI being the most popular segment, accounting for 43% of the financing [6] - From January to November 2025, there were 24 financing deals in the BCI field, reflecting a 30% year-on-year increase, indicating strong investor interest [6]

2026年首个交易日，A股市场迎来"开门红"，上证指数重新站上4000点。1月6日，上证指数又走出13连 阳的新纪录，报收4083.67点，再创十年新高；两市及北交所共4101只股票上涨。 从板块来看，脑机接口概念延续强势，十余只成分股涨停，三博脑科、美好医疗、创新医疗2连板。被 视为"牛市旗手"或"市场风向标"的券商股强劲上行，华林证券冲上涨停，华安证券、东北证券等多股大 涨。有色金属板块表现活跃，洛阳钼业、紫金矿业等多股创历史新高。商业航天概念反复活跃。 这种从"模式创新"向"底层技术创新"的偏好反转，体现了投资者对中国经济高质量发展的坚定信心。科 技不再是市场的点缀，而是成为了定盘星，重构了资本市场的估值体系与成长逻辑。 与此同时，作为"牛市旗手"的券商股与作为"价值压舱石"的有色金属板块交相辉映，构成了市场上涨的 双翼。券商股的爆发，折射出市场信心的全面修复以及对资本市场制度改革红利的预期；而洛阳钼业、 紫金矿业等资源巨头创下历史新高，则反映了在全球通胀预期与工业硬需求下，中国核心资产在全球配 置中的独特性与稀缺性。 这种"科技领航、金融助攻、资源筑底"的良性互动，标志着市场进入了一个更加成熟、更加均 ...